accessibility menu, dialog, popup

UserName
Viewing profile as user:

Thienopyridines

Organic heterocyclic compounds that consist of a thiophene ring fused to a pyridine ring.
Molecular Weight (g/mol) 
  • (1)
  • (2)
  • (3)
  • (2)
  • (2)
  • (2)
  • (2)
  • (1)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (4)
  • (1)
  • (2)
  • (1)
Quantity 
  • (11)
  • (1)
  • (1)
  • (5)
  • (5)
  • (7)
Percent Purity 
  • (2)
  • (2)
  • (4)
  • (2)
  • (1)
  • (2)
  • (3)
  • (5)
  • (3)
Physical Form 
  • (8)
  • (1)
  • (2)
  • (1)
Boiling Point 
  • (1)
  • (2)
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

special offers

  • (4)

brands

  • (3)
  • (1)
  • (84)
  • (144)
  • (5)
  • (3)
  • (1)
  • (25)
  • (46)
  • (110)
  • (2)
  • (2)
  • (2)
  • (7)
  • (10)
  • (10)
  • (1)

special interests

  • (113)

Molecular Weight (g/mol)

  • (1)
  • (2)
  • (3)
  • (2)
  • (2)
  • (2)
  • (2)
  • (1)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (4)
  • (1)
  • (2)
  • (1)

Quantity

  • (11)
  • (1)
  • (1)
  • (5)
  • (5)
  • (7)

Percent Purity

  • (2)
  • (2)
  • (4)
  • (2)
  • (1)
  • (2)
  • (3)
  • (5)
  • (3)

Physical Form

  • (8)
  • (1)
  • (2)
  • (1)

Boiling Point

  • (1)
  • (2)
  • (1)

Product Line

  • (1)

Search Within Results
Keyword Search:
391 – 405 of 452 results
391

eMolecules​ 65075-96-9 | Thieno[2,3-b]pyridin-4-ol | J & W PharmLab LLC | MFCD18802558 | 151.180 | C7H5NOS | 96.000 | Oc1ccnc2sccc12 | 5g | 289355375

Thieno[2,3-b]pyridin-4-ol | J & W PharmLab LLC | 65075-96-9 | MFCD18802558 | 151.180 | C7H5NOS | 96.000 | Oc1ccnc2sccc12 | 5g | 289355375

ENCOMPASS_PREFERRED
392

Chemscene CHEMSCENE

5000576706 2 3-DIHYDROTHIENO 3 4-B 1 10G

ENCOMPASS_PREFERRED
393

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000772138 TERT-BUTYL 1-2-AMI 250MG

ENCOMPASS_PREFERRED
394

Medchemexpress LLC TERT-BUTYL 2-2-AMI 100 mg
SDP

TERT-BUTYL 2-2-AMI 100MG

ENCOMPASS_PREFERRED
395

Aobchem 1-(2 3-Dihydrothieno[3 4-b]-1 4-dioxin-5-yl)-2 2-difluoro-1-propanone | 95% | CAS 2004336-74-5 | C9H8F2O3S | 1g

1-(2 3-Dihydrothieno[3 4-b]-1 4-dioxin-5-yl)-2 2-difluoro-1-propanone | 95% | CAS 2004336-74-5 | C9H8F2O3S | 1g

ENCOMPASS_PREFERRED
396

Medchemexpress LLC TERT-BUTYL N-2-AMI 5G
SDP

TERT-BUTYL N-2-AMI 5G

ENCOMPASS_PREFERRED
397

Chemscene CHEMSCENE

5000576823 R-2-TERT-BUTOXYCARBONYL AMI 5G

ENCOMPASS_PREFERRED
398

Medchemexpress LLC TERT-BUTYL 3-3-AMI 100 mg
SDP

TERT-BUTYL 3-3-AMI 100MG

ENCOMPASS_PREFERRED
399

Medchemexpress LLC TERT-BUTYL N-3-AMI 500 mg
SDP

TERT-BUTYL N-3-AMI 500MG

ENCOMPASS_PREFERRED
400

Medchemexpress LLC TERT-BUTYL 3-3-AMI 500 mg
SDP

TERT-BUTYL 3-3-AMI 500MG

ENCOMPASS_PREFERRED
401

Medchemexpress LLC TERT-BUTYL N-4-AMI 1G
SDP

TERT-BUTYL N-4-AMI 1G

ENCOMPASS_PREFERRED
402

Ambeed AMBEED

5000847379 5-BROMONAPHTHALEN-2-AMI 1G

ENCOMPASS_PREFERRED
403

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000742025 2S 3R-2-S-2-AMI 1MG

ENCOMPASS_PREFERRED
404

Medchemexpress LLC (R,1R)-Tenofovir amibufenamide | 1571076-37-3 | 98.9% | 490.49 | 1 ML
SDP

(R,1R)-Tenofovir amibufenamide is used for purifying a tenofovir prodrug. Tenofovir is a nucleoside reverse transcriptase inhibitor.

  • Used for purifying a tenofovir prodrug
  • Functions as a nucleoside reverse transcriptase inhibitor

ENCOMPASS_PREFERRED
405

Medchemexpress LLC AMI-1 free acid | 134-47-4 | 99.5% | 504.49 | 1 ML
SDP

AMI-1 free acid is a potent, cell-permeable, and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM for human PRMT1 and 3.0 μM for yeast-Hmt1p. It exerts its inhibitory effects on PRMTs by blocking peptide-substrate binding.

  • Potent, cell-permeable, and reversible inhibitor of PRMTs.
  • Inhibits type I PRMTs and type II PRMT5.
  • Specifically inhibits arginine methyltransferase activity, not lysine, and does not compete for the AdoMet binding site.
  • Inhibits methylation of GFP-Npl3 and cellular proteins.
  • Inhibits the cell viability of sarcoma in S180 and U2OS cells in a time- and dose-dependent manner in vitro.
  • Reduces S180 cell viability through the induction of cell apoptosis.
  • Inhibits S180 viability in vivo.
  • Downregulates PRMT5 and decreases levels of H4R3me2s and H3R8me2s in a tumor xenograft model.

ENCOMPASS_PREFERRED